India Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Solara Active Pharma Sciences Ltd (BOM:541540) Q4 2024 Earnings Call Transcript Highlights: Strong Margin Improvement and Strategic Initiatives
Solara Active Pharma Sciences Ltd (BOM:541540) reports significant gross margin improvement and outlines strategic initiatives for FY25. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Eris Lifesciences Ltd (BOM:540596) Q1 2025 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Acquisitions
Eris Lifesciences Ltd (BOM:540596) reports a 54% year-on-year revenue growth and significant margin improvements in Q1 2025. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Eris Lifesciences Ltd (BOM:540596) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Acquisitions
Eris Lifesciences Ltd (BOM:540596) reports robust financial performance with significant growth in revenue and EBITDA, while outlining future debt reduction and expansion plans. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Alkem Laboratories Ltd (BOM:539523) Q4 2024 Earnings Call Transcript Highlights: Record Profits and Strategic Investments
Alkem Laboratories Ltd (BOM:539523) reports significant growth in international revenue and improved EBITDA margins, while addressing challenges in the domestic market. Sep 13, 2024
GuruFocus Research Drug Manufacturers
Indoco Remedies Ltd (BOM:532612) Q1 2025 Earnings Call Transcript Highlights: Revenue Decline Amid Strategic Growth Initiatives
Despite a dip in net revenue, Indoco Remedies Ltd (BOM:532612) focuses on new product launches and market expansions to drive future growth. Sep 13, 2024